HealthCor Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.87M Sell
110,000
-193,500
-64% -$4.63M 2.63% 6
2022
Q3
$6.78M Buy
+303,500
New +$7.89M 0.85% 36
2022
Q2
Sell
-140,630
Closed -$3.7M 60
2022
Q1
$3.7M Buy
+140,630
New +$3.48M 0.25% 47
2013
Q4
Sell
-825,000
Closed -$27.7M 51
2013
Q3
$27.7M Hold
825,000
1.49% 26
2013
Q2
$23.7M Buy
+825,000
New +$24M 1.43% 25

Other funds holding ALKS

HealthCor Management's ALKS Position: Q4 2022 in Review

HealthCor Management reduced its Alkermes (ALKS) stake by 64% in Q4 2022, selling an estimated $4.63M and leaving 110,000 shares worth $2.87M. The position accounts for 2.63% of the portfolio, ranked #6.

HealthCor Management first reported a position in ALKS in Q2 2013 and has held it in 5 quarters since. The position peaked at $27.7M in Q3 2013. 279 funds tracked by Wall St. Rank hold ALKS as of Q4 2022.

  • HealthCor Management held 110,000 shares of Alkermes worth $2.87M as of Q4 2022.
  • HealthCor Management sold 193,500 Alkermes shares in Q4 2022, an estimated $4.63M.
  • Alkermes made up 2.63% of HealthCor Management's portfolio in Q4 2022, its #6 holding.
  • HealthCor Management first reported a position in Alkermes in Q2 2013 and has held it in 5 quarters since.
  • HealthCor Management's Alkermes position peaked at $27.7M in Q3 2013.
  • 279 funds tracked by Wall St. Rank held Alkermes as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.